Among 19,654 NHANES adults aged 20 to 79 with cardiovascular-kidney-metabolic (CKM) syndrome stages 1 to 4, meeting baseline physical activity guidelines was linked to lower all-cause mortality (HR 0.774, 95% CI 0.675-0.888) and lower cardiovascular mortality (HR 0.707, 95% CI 0.547-0.914) over 134,037 person-years and 1,190 deaths. Stage-specific hazard ratios were 1.030, 0.803, 0.642 and 0.727 for stages 1 to 4. Absolute five-year risk reductions grew from near zero at stage 1 to 3.84 percentage points at stage 4.
The pattern that matters most is the absolute gain: the people with the most advanced disease had the largest five-year reduction in death risk, and only that interval clearly excluded the null. That fits earlier cohort work showing activity helps people with kidney disease, diabetes and heart disease, but few studies have laid out the gradient across the full AHA staging framework. Caution is warranted. This is a preprint and has not been peer reviewed, so numbers may shift. Activity was measured once at baseline by self-report, and reverse causation is a serious concern, since sicker people move less and die sooner. Propensity weighting cannot fully remove that, and the stage-specific hazard ratios were nonmonotonic, with stage 1 showing no benefit. The authors themselves note the work cannot estimate what an activity-promotion program would achieve. Overall, this is confirmatory rather than paradigm-shifting: it supports existing guidance that adults with CKM conditions should discuss safe, regular activity with their clinicians.